04:41 PM EDT, 05/16/2024 (MT Newswires) -- Christopher Causey, Director, on May 15, 2024, sold 2,000 shares in United Therapeutics ( UTHR ) for $545,800. Following the Form 4 filing with the SEC, Causey has control over a total of 4,185 shares of the company, with 4,185 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000141588924013353/xslF345X03/form4-05162024_040513.xml